Table 2.
Detailed information on the included studies.
| References | Range age population at baseline | N | Mean or median age | Pathology/treatment | Time of measures | Country | Study design | Quality assessment (researcher 1) | Quality assessment (researcher 2) |
|---|---|---|---|---|---|---|---|---|---|
| Andersson et al. (2013) | 23–53 | 17 | 45 | MI | During the 1st year following their MI | Sweden | Qualitative (interpretative phenomenological analysis, IPA) | 85 | 83 |
| Beckman et al. (2016) | 18–55 | 3,437 | 47 | MI | Within 24 h after MI + 1 month + 12 months | USA and Spain | Quantitative | 85 | 83 |
| Brummett et al. (2004) | <55 | No data | No data | CAD (cardiac catheterization) | Hospitalization + 1 month post-catheterization + 3-month intervals over 2 years | USA | Quantitative | 63 | 73 |
| Bucholz et al. (2014) | 18–55 | 3,432 | 48 | MI | Initial hospitalization + 1 month + 12 months | USA and Spain | Quantitative | 88 | 83 |
| Deasy et al. (2012) | 29–41 | 56 | 35 | Cardiac arrest | 5 years after the event (range 2.7/8.6 years) | Australia | Quantitative | 75 | 80 |
| Dostálová et al. (2017) | <45 | 76 | No data | MI | <5 years after the event | Czech Republic | Quantitative | 60 | 58 |
| Dreyer et al. (2015) | 18–55 | 3,501 | 47 | MI | Hospitalization, 1 and 12 months post-AMI | USA and Spain | Quantitative | 83 | 88 |
| Dreyer et al. (2016) | 18–55 | 436 | No data | CAD (pre-MI) | Hospitalization | USA and Spain | Quantitative | 83 | 85 |
| Hinz et al. (2011) | 30–39/40–49 | 652 | No data | MI (or bypass) | At the beginning of their rehabilitation | Germany | Quantitative | 70 | 75 |
| Joubert et al. (2013) | <55 | 30 | 47.7 | MI | Hospitalization, 3 and 6 months | Australia | Quantitative and qualitative | 63 | 65 |
| Koutrolou-Sotiropoulou et al. (2016) | >18 | 116 | 36 | Peripartum cardiomyopathy (HF) | 0.2 to 24 years after the event | USA | Quantitative and qualitative | 65 | 68 |
| Lacharity (1999) | 31–47 | 11 | 40 | CAD | 4 months to 10 years after the event | USA | Qualitative (ethnographic) | 70 | 65 |
| Lavie and Milani (2006) | 22–54 | 104 | 48 | CAD | Baseline 2–6 weeks after CAD event + 1 week later | USA | Quantitative | 60 | 75 |
| Leung Yinko et al. (2014) | 18–55 | 1,123 | 49 | ACS | Baseline (48 h after admission) + 1 month + 6 months + 12 months | Canada, USA, and Switzerland | Quantitative | 73 | 80 |
| Leung Yinko et al. (2015) | 18–55 | 740 | 50 | ACS | 48 h after admission + 1 year later | Canada, USA, and Switzerland | Quantitative | 73 | 73 |
| Lindau et al. (2014) | 18–55 | 3,498 | 48 | MI | Hospitalization + 1 month post-MI | USA and Spain | Quantitative | 83 | 83 |
| Lindau et al. (2016) | 18–55 | 2,802 | 48 | MI | Hospitalization + 1 month post-MI + 1 year | USA and Spain | Quantitative | 80 | 83 |
| Lukkarinen and Hentinen (1997) | 35–54 | No data | No data | CHD | 1 or 2 years after medication prescribed for group 1; right before the surgery in the other groups | Finland | Quantitative | 65 | 65 |
| Lukkarinen and Hentinen (1998) | 35–54 | 80 | No data | CAD | 1 or 2 years after medication prescribed for group 1; right before the surgery in the other groups | Finland | Quantitative | 70 | 70 |
| McAnirn et al. (2015) | 35–47 | 7 | 42 | MI | 6–8 weeks after the event | UK | Qualitative (Heideggerian phenomenological) | 75 | 78 |
| Merritt et al. (2017) | 29–44 | 10 | 40.1 | MI | 116 mean days since MI | UK | Qualitative (IPA) | 90 | 88 |
| Pelletier et al. (2016a) | 42–54 | 909 | 48 | ACS | Hospitalization (within 24 h of admission) + 12 months | Canada, USA, and Switzerland | Quantitative | 70 | 75 |
| Schweikert et al. (2009) | 45–54 | No data | No data | MI | 7.4 median years since first MI | Germany | Quantitative | 80 | 85 |
| Shah et al. (2014) | <55 | 851 | No data | CAD (angina, MI, and HF) | The day of or before cardiac catheterization | USA | Quantitative | 78 | 83 |
| Uusküla (1996) | 30–44 | 64 | 37.3, 38.6 | MI | Between 4 and 7 days after infarction | Estonia | Quantitative | 55 | 50 |
| Vaccarino et al. (2014) | 38–50 | 49 | No data | MI | Within 6 months (5 months median time) after the event | USA | Quantitative and visual | 73 | 78 |
| Vaccarino et al. (2016) | 34–50 | 68 | No data | CHD | At least 1 week after the event | USA | Quantitative and visual | 80 | 78 |
| Waldron et al. (2017) | 19–29 | 9 | No data | HT (dilated cardiomyopathy, restrictive cardiomyopathy, and previous medical treatments) | 7 months to 9.5 years (mean 3.6 years) after the event | UK | Qualitative (IPA) | 88 | 90 |
| Wong et al. (2013) | 20–39/40–49 | 658 | No data | HF (ICM, valvular, and ischemic HD) | At least 4 weeks after the event | USA and Canada | Quantitative | 68 | 65 |
| Xu et al. (2015) | 18–55 | 3,572 | MI | Baseline + 1 month | USA, Spain, and Australia | Quantitative | 75 | 85 | |
| Xu et al. (2017) | 18–55 | 3,509 | 47 | MI | Screening at baseline 3 days after admission + 1 month + 12 months | USA, Spain, and Australia | Quantitative | 85 | 90 |
| Zipori-Beckenstein et al. (1999) | 18–55 | 57 | No data | Cardiac catheterization | Right before catheterization and 6 weeks later | Israel | Quantitative | 63 | 63 |
MI, myocardial infarction; CHD, coronary heart disease; CAD, coronary artery disease; ACS, acute coronary syndrome; HF, heart failure; ICM, idiopathic cardiomyopathy; HT, heart transplant; HD, heart disease.